Clinical trials
Temporomandibular Joint Disorders trials in Brazil with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 7 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Nove de Julho | 10 |
| University of Sao Paulo | 3 |
| Daniela Ap. Biasotto-Gonzalez | 2 |
| Universidade Federal do Ceara | 2 |
| University of Sao Paulo General Hospital | 2 |
| Federal University of Pelotas | 1 |
| Federal University of Rio Grande do Sul | 1 |
| Federal University of São Paulo | 1 |
| Instituto Brasileiro de Osteopatia | 1 |
| Universidade Federal Fluminense | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Temporomandibular Joint Disorders | 28 |
| Facial Pain | 4 |
| Temporomandibular Joint Dysfunction Syndrome | 3 |
| Musculoskeletal Diseases | 2 |
| Pain | 2 |
| Agnosia | 1 |
| Chronic Pain | 1 |
| Communication Disorders | 1 |
| Myalgia | 1 |
| Ocular Motility Disorders | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.